Viscoelastic point-of-care testing to guide transfusion and antithrombotic therapy in perioperative and critically ill patients: are all parameters created equal?

Anaesthesia and Intensive Care

Volumn 44, Issue 1, 2016, Pages 11-13

  Harahsheh, Y ^a   Ho, K M ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

BLOOD TRANSFUSION; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; HUMAN; POINT OF CARE TESTING;

BLOOD TRANSFUSION; CRITICAL ILLNESS; FIBRINOLYTIC AGENTS; HUMANS; POINT-OF-CARE TESTING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85004115692     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057X1604400103     Document Type: Editorial

References (23)

1. Miao X, Liu J, Zhao M, Cui Y, Feng Z, Zhao J et al. The influence of cardiopulmonary bypass priming without FFP on postopera-tive coagulation and recovery in pediatric patients with cyanotic congenital heart disease. Eur J Pediatr 2014; 173:1437-1443.
2. Toukh M, Siemens DR, Black A, Robb S, Leveridge M, Graham CH et al. Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res 2014; 133:88-95.
3. Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de Wolf JT. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 2010; 110:987-994.
4. Kiliç Y, Topçu I, Bambal H, Civi M. Thromboelastography in the evaluation of coagulation disorders in patients with sepsis. Turk J Med Sci 2014; 44:267-272.
5. Durila M, Bures J, Pelichovská M, Cvavhovec K. Hypocoagulation state in severe systemic inflammatory response syndrome/sepsis is consistent with endogenous heparinoid effect as detected by thromboelastography. Anaesth Intensive Care 2011; 39:508-509.
6. Senzolo M, Agarwal S, Zappoli P, Vibhakorn S, Mallett S, Burroughs AK. Heparin-like effect contributes to the coagulopa-thy in patients with acute liver failure undergoing liver transplan-tation. Liver Int 2009; 29:754-759.
7. Matzelle SJ, Gibbs NM, Weightman W, Sheminant M, Rowe R, Baker S. Systemic anticoagulant effect of low-dose subcutaneous unfractionated heparin as determined using thrombelastogra-phy. Anaesth Intensive Care 2007; 35:498-504.
8. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 2012; 38:62-68.
9. Lang T, von Depka M. Possibilities and limitations of thromboelastometry/-graphy. Hamostaseologie 2006; 26:S20-S29.
10. Louis SG, Van PY, Riha GM, Barton JS, Kunio NR, Underwood SJ et al. Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg 2014; 76:937-942.
11. Adelmann D, Wiegele M, Wohlgemuth RK, Koch S, Frantal S, Quehenberger P et al. Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry. Thromb Res 2014; 134:918-923.
12. Gibbs NM. Hypocoagulability, hypercoagulability and the inter-pretation of 'normal' kaolin-activated thrombelastographs in the perioperative period. Anaesth Intensive Care 2011; 39:802-803.
13. Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N et al. Viscoelastic point-of-care testing to assist with the diagno-sis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015; 19:1-228.
14. Haas T, Spielmann N, Restin T, Seifert B, Henze G, Obwegeser J et al. Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: A prospective randomised controlled trial. Br J Anaesth 2015; 115:234-243.
15. Duff OC, Ho KM, Maybrook S. In-vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: a prospective case-control study. Anaesth Intensive Care 2012; 40:472-478.
16. Hincker A, Feit J, Sladen RN, Wagener G. Rotational thromboe-lastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care 2014; 18:549.
17. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postop-erative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100:1576-1583.
18. Zmuda K, Neofotistos D, Ts'ao CH. Effects of unfractionated hep-arin, low-molecular-weight heparin, and heparinoid on throm-boelastographic assay of blood coagulation. Am J Clin Pathol 2000; 113:725-731.
19. Levin AI, Heine AM, Coetzee JF, Coetzee A. Heparinase throm-boelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2014; 28:224-229.
20. Prakash S, Wiersema UF, Bihari S, Roxby D. Discordance between ROTEM® clotting time and conventional tests during unfraction-ated heparin based anticoagulation in intensive care patients on extracorporeal membrane oxygenation. Anaesth Intensive Care 2016; 44:85-92.
21. Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen M, Johansson PI et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care 2014; 18:R52.
22. Ho KM, Duff OC. Predictors of an increased in vitro thrombotic and bleeding tendency in critically ill trauma and non-trauma patients. Anaesth Intensive Care 2015; 43:317-322.
23. Solomon C, Rahe-Meyer N. Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L. Blood Transfus 2015; 13:248-254.